Literature DB >> 30274977

Redesigning Prostate Cancer Screening Strategies to Reduce Overdiagnosis.

Andrew J Vickers1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30274977      PMCID： PMC6709846          DOI： 10.1373/clinchem.2018.287094

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  13 in total

Review 1.  The effect of provider case volume on cancer mortality: systematic review and meta-analysis.

Authors:  Russell L Gruen; Veronica Pitt; Sally Green; Anne Parkhill; Donald Campbell; Damien Jolley
Journal:  CA Cancer J Clin       Date:  2009 May-Jun       Impact factor: 508.702

2.  Follow-up of Prostatectomy versus Observation for Early Prostate Cancer.

Authors:  Timothy J Wilt; Karen M Jones; Michael J Barry; Gerald L Andriole; Daniel Culkin; Thomas Wheeler; William J Aronson; Michael K Brawer
Journal:  N Engl J Med       Date:  2017-07-13       Impact factor: 91.245

3.  A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.

Authors:  Dipen J Parekh; Sanoj Punnen; Daniel D Sjoberg; Scott W Asroff; James L Bailen; James S Cochran; Raoul Concepcion; Richard D David; Kenneth B Deck; Igor Dumbadze; Michael Gambla; Michael S Grable; Ralph J Henderson; Lawrence Karsh; Evan B Krisch; Timothy D Langford; Daniel W Lin; Shawn M McGee; John J Munoz; Christopher M Pieczonka; Kimberley Rieger-Christ; Daniel R Saltzstein; John W Scott; Neal D Shore; Paul R Sieber; Todd M Waldmann; Fredrick N Wolk; Stephen M Zappala
Journal:  Eur Urol       Date:  2014-10-27       Impact factor: 20.096

4.  Time trends and local variation in primary treatment of localized prostate cancer.

Authors:  Matthew R Cooperberg; Jeanette M Broering; Peter R Carroll
Journal:  J Clin Oncol       Date:  2010-02-01       Impact factor: 44.544

5.  National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.

Authors:  Michael W Drazer; Sandip M Prasad; Dezheng Huo; Mara A Schonberg; William Dale; Russell Z Szmulewitz; Scott E Eggener
Journal:  Cancer       Date:  2014-02-12       Impact factor: 6.860

6.  Quantifying the role of PSA screening in the US prostate cancer mortality decline.

Authors:  Ruth Etzioni; Alex Tsodikov; Angela Mariotto; Aniko Szabo; Seth Falcon; Jake Wegelin; Dante DiTommaso; Kent Karnofski; Roman Gulati; David F Penson; Eric Feuer
Journal:  Cancer Causes Control       Date:  2007-11-20       Impact factor: 2.506

7.  Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Authors:  Fritz H Schröder; Jonas Hugosson; Monique J Roobol; Teuvo L J Tammela; Marco Zappa; Vera Nelen; Maciej Kwiatkowski; Marcos Lujan; Liisa Määttänen; Hans Lilja; Louis J Denis; Franz Recker; Alvaro Paez; Chris H Bangma; Sigrid Carlsson; Donella Puliti; Arnauld Villers; Xavier Rebillard; Matti Hakama; Ulf-Hakan Stenman; Paula Kujala; Kimmo Taari; Gunnar Aus; Andreas Huber; Theo H van der Kwast; Ron H N van Schaik; Harry J de Koning; Sue M Moss; Anssi Auvinen
Journal:  Lancet       Date:  2014-08-06       Impact factor: 79.321

Review 8.  Whom to Biopsy: Prediagnostic Risk Stratification with Biomarkers, Nomograms, and Risk Calculators.

Authors:  Stacy Loeb; Hasan Dani
Journal:  Urol Clin North Am       Date:  2017-11       Impact factor: 2.241

9.  Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening: population based cohort study.

Authors:  Sigrid Carlsson; Melissa Assel; Daniel Sjoberg; David Ulmert; Jonas Hugosson; Hans Lilja; Andrew Vickers
Journal:  BMJ       Date:  2014-03-28

10.  Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.

Authors:  Andrew J Vickers; Daniel D Sjoberg; David Ulmert; Emily Vertosick; Monique J Roobol; Ian Thompson; Eveline A M Heijnsdijk; Harry De Koning; Coral Atoria-Swartz; Peter T Scardino; Hans Lilja
Journal:  BMC Med       Date:  2014-02-11       Impact factor: 8.775
View more
  4 in total

Review 1.  The current status of risk-stratified breast screening.

Authors:  Ash Kieran Clift; David Dodwell; Simon Lord; Stavros Petrou; Sir Michael Brady; Gary S Collins; Julia Hippisley-Cox
Journal:  Br J Cancer       Date:  2021-10-26       Impact factor: 9.075

2.  An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.

Authors:  Michael B Cook; Lauren M Hurwitz; Ashley M Geczik; Eboneé N Butler
Journal:  Eur Urol       Date:  2020-10-20       Impact factor: 20.096

3.  HILIC-MRM-MS for Linkage-Specific Separation of Sialylated Glycopeptides to Quantify Prostate-Specific Antigen Proteoforms.

Authors:  Yuri E M van der Burgt; Kasper M Siliakus; Christa M Cobbaert; L Renee Ruhaak
Journal:  J Proteome Res       Date:  2020-03-18       Impact factor: 4.466

4.  Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice.

Authors:  Michelle M A Kip; Martijn L J Oonk; Mark-David Levin; Annemarie Schop; Patrick J E Bindels; Ron Kusters; Hendrik Koffijberg
Journal:  BMC Med Inform Decis Mak       Date:  2020-07-31       Impact factor: 2.796
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.